MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
31.97
+1.43 (4.68%)
At close: Dec 5, 2025, 4:00 PM EST
31.35
-0.62 (-1.94%)
After-hours: Dec 5, 2025, 7:49 PM EST

MBX Biosciences Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for MBX Biosciences stock have an average target of 50.71, with a low estimate of 18 and a high estimate of 80. The average target predicts an increase of 58.62% from the current stock price of 31.97.

Analyst Consensus: Buy
Target Low Average Median High
Price $18 $50.71 $50 $80
Change -43.70% +58.62% +56.40% +150.23%

Analyst Ratings

The average analyst rating for MBX Biosciences stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jul '25Aug '25Sep '25Oct '25Nov '25Dec '25
Strong Buy 344344
Buy 344333
Hold 000000
Sell 000000
Strong Sell 000001
Total 688678

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Goldman Sachs
Goldman Sachs
Strong Sell
Initiates
$18
Strong Sell Initiates $18 -43.70% Dec 4, 2025
Guggenheim
Guggenheim
Strong Buy
Maintains
$84$77
Strong Buy Maintains $84$77 +140.85% Nov 10, 2025
TD Cowen
TD Cowen
Strong Buy
Initiates
n/a
Strong Buy Initiates n/a n/a Nov 4, 2025
Truist Securities
Truist Securities
Strong Buy
Initiates
$50
Strong Buy Initiates $50 +56.40% Oct 15, 2025
Mizuho
Mizuho
Buy
Maintains
$38$56
Buy Maintains $38$56 +75.16% Sep 24, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.64
from -5.82
EPS Next Year
-3.08
from -2.64
Fiscal Year FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028
Period Ending Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028
Revenue
------37.37M
Revenue Growth
-------
EPS
-39.18-31.96-5.82-2.64-3.08-3.85-3.43
EPS Growth
-------
Forward PE
-------
No. Analysts ---1010106
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027202820292030
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 202520262027202820292030
High - -
Avg - -
Low - -

EPS Forecast

EPS 202520262027202820292030
High -2.31 -2.21
Avg -2.64 -3.08
Low -2.76 -4.49

EPS Growth

EPS Growth 202520262027202820292030
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.